#1 Ranked Children’s Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
Achondroplasia is a genetic bone disorder, affecting one in 20,000 babies. It is the most common type of dwarfism in which the child's arms and legs are short in proportion to body length. The head is often large and the trunk is normal size. The average height of adult males with achondroplasia is 52 inches (or 4 feet, 4 inches) and the average height of adult females with achondroplasia is 49 inches (or 4 feet, 1 inch).
Children with achondroplasia can be seen in the Genetics Program or the Advanced Fetal Care Program at Boston Children's Hospital.
Researchers are looking into a family of genes called fibroblast growth factors. The gene that causes achondroplasia is included in this category. The goal is to understand how the faulty gene causes the features seen in achondroplasia in order to lead to improved treatment. These genes have been linked to other types of inherited skeletal disorders.
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”